Window shopping for health plans for 2017 began Monday on the federal Obamacare exchange HealthCare.gov. » Read More
By: Bertha Coombs
Unlike an flexible savings account, health savings account funds don't expire at the end of the year and they're portable. » Read More
Regulators said they have told Mylan that it should be paying higher rebates on sales of EpiPens through Medicaid.
Aetna will be giving 50,000 of its employees free Apple Watches and will deduction to customers buying them, reported NBC Connecticut.
Young adults continue to have high rates of uninsurance despite gains made under Obamacare.
A restatement by Mylan of EpiPen profit figures is just the latest problem for the drugmaker.
The cost of naloxone has spiraled upwards, even as the drug has become more desperately needed to reverse overdoses.
If implemented, Clinton's plan would increase the number of Americans insured while Trump's would not.
The nation's uninsured rate would spike under Trump's health plan, but fall further under Clinton's, a study finds.
The days of company pensions are long gone for most workers; that is why investing in an annuity can be an appealing strategy for retirees.
John Nelson, Lloyd's of London chairman, discusses the specialist insurance company's latest results and says market conditions are challenging.
Mylan also faces heat from multiple regulatory and legal agencies over huge cost increases for the anti-allergy auto-injectors.
Start-ups, such as Lemonade and Teambrella, are using peer-to-peer strategies to disrupt to the trillion-dollar insurance industry.
Mylan CEO Heather Bresch is set to testify Wednesday before a House committee over sky-high price hikes for lifesaving EpiPens.
Less than 10 percent of authorized doctors prescribe the medication buprenorphine to more than 75 patients.
ICICI Bank CEO Chanda Kochhar says the listing of ICICI Prudential life Insurance is huge leap forward for India's capital markets and financial sector.
Despite rising Obamacare prices, the total premiums paid in many cases are less than work-based coverage.
Drugmakers need to learn empathy and not try to defend price hikes that make drugs inaccessible, GSK CEO Andrew Witty told CNBC.
Get the best of CNBC in your inbox